St. Paul, Minn.-based RespirTech was founded in 2004 and has approximately 210 employees. The company produces airway clearance devices for patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease and cystic fibrosis.
Philips said that the addition of RespirTech’s portfolio will allow Philips to “accelerate its growth in respiratory care,” specifically for COPD patients with bronchiectasis. The acquired portfolio includes a clinical support program for managing respiratory patients at home, and Philips said it will support their own clinically focused service plans.
RespirTech produces the inCourage system pulsating vest designed to aid in respiration at home and the single patient-use ClearChest comfort vest and bands for hospital use, which use rhythmic inflation and deflation against a patient’s chest to help clear the lungs.
“With this transaction, we will broaden our portfolio with a proven therapy to enable patients with chronic respiratory disorders manage their condition and receive the care they need in the home. RespirTech’s vest therapy can be applied to a range of respiratory conditions and various neuromuscular diseases, where patients’ compromised abilities to cough often leads to serious respiratory complications and associated higher care costs. By helping these patients help themselves, we aim to enhance the patient’s quality of life and reduce the overall cost of care,” sleep & respiratory care biz lead John Frank said in a press release.